AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP Form_NN 20-F_NNP Information_NNP 2003_CD 87_CD 22_CD Net_JJ cash_NN inflow_NN from_IN trading_NN operations_NNS 2003 2002 2001_CD $_$ m_CD $_$ m_CD $_$ m_CD Operating_NN profit_NN before_IN exceptional_JJ items_NNS 4,111_CD 4,356_CD 4,156_CD Depreciation_NN and_CC amortisation_NN 1,290_CD 960_CD 860_CD Stocks_NNS increase_NN decrease_NN 131 101 417_CD Debtors_NNS increase_NN decrease_NN 540 198 138_CD Creditors_NNS increase_NN decrease_NN 430 402 727_CD Other_JJ non-cash_JJ movements_NNS 317_CD 65_CD 120_CD 4,617_CD 5,686_CD 4,130_CD 23_CD Cash_NN flows_VBZ related_VBN to_TO exceptional_JJ items_NNS Current_JJ period_NN cash_NN flow_NN related_VBN to_TO exceptional_JJ items_NNS and_CC merger_NN 2003 2002 2001_CD related_JJ payments_NNS ,_, before_IN associated_VBN tax_NN charge_NN relief_NN $_$ m_CD $_$ m_CD $_$ m_CD Synergy_NNP and_CC integration_NN costs_NNS 25_CD 68_CD 312_CD Zoladex_NNP OIG_NNP settlement_NN 355_CD Costs_NNS relating_VBG to_TO disposals_NNS and_CC demerger_NN of_IN other_JJ businesses_NNS 11_CD 25_CD 56_CD Outflow_NN related_VBN to_TO exceptional_JJ items_NNS 391_CD 93_CD 368_CD Proceeds_NNS from_IN disposal_NN of_IN fixed_JJ assets_NNS accounted_VBD for_IN as_IN exceptional_JJ 10_CD Exceptional_JJ items_NNS cash_NN flow_NN 391_CD 93_CD 358_CD 24_CD Acquisitions_NNS of_IN subsidiaries_NNS and_CC purchases_NNS of_IN minority_NN interests_NNS There_EX were_VBD no_DT significant_JJ business_NN acquisitions_NNS in_IN any_DT of_IN the_DT years_NNS presented_VBN ._.
All_DT acquisitions_NNS have_VBP been_VBN accounted_VBN for_IN by_IN the_DT purchase_NN method_NN of_IN accounting_NN ._.
2003 2002 2001_CD Total_JJ Total_JJ Total_JJ fair_JJ fair_JJ fair_JJ value_NN value_NN value_NN $_$ m_CD $_$ m_CD $_$ m_CD Fixed_VBN assets_NNS 4_CD Current_JJ assets_NNS 26_CD Creditors_NNS due_JJ within_IN one_CD year_NN 16_CD Provisions_NNS for_IN liabilities_NNS and_CC charges_NNS 1_CD Fair_NNP value_NN of_IN net_JJ assets_NNS acquired_VBN 13_CD Goodwill_NNP acquired_VBD 41_CD Consideration_NN for_IN subsidiaries_NNS and_CC operations_NNS acquired_VBD 54_CD Purchases_NNS of_IN minority_NN interests_NNS 7_CD 47_CD Less_RBR :_: Cash_NN included_VBD in_IN undertaking_VBG acquired_VBN 3_CD Net_JJ cash_NN consideration_NN 44_CD Assets_NNS and_CC liabilities_NNS were_VBD adjusted_VBN to_TO their_PRP$ fair_JJ values_NNS based_VBN on_IN external_JJ valuations_NNS and_CC internal_JJ assessments_NNS ._.
There_EX were_VBD no_DT significant_JJ differences_NNS between_IN book_NN and_CC fair_JJ values_NNS in_IN respect_NN of_IN the_DT acquisitions_NNS made_VBN ._.
